Abstract:To investigate the potential value of magnetic resonance imaging (MRI) in assessing response and prognostic relevance to total neoadjuvant treatment (TNT) in locally advanced rectal cancer (LARC) with high risk factors. This was a retrospective study of pre-, during, and post-TNT MRI of patients with LARC with high risk factors who underwent TNT before operation. Patients received three cycles of induction chemotherapy (ICT) followed by neoadjuvant radiotherapy and 2 cycles of concurrent chemotherapy (CRT).After that, 3 cycles of consolidation chemotherapy (CCT) were delivered. Radiation dose of pelvic IMRT/VMRT was 50.4 Gy/28f. MRI scans were performed before TNT (baseline), after CRT (post-CRT) and after CCT(post-CCT), respectively. MRI parameters such as the apparent diffusion coefficient (ADC) values of tumor, T2 adjusted values of tumor (T2 values of tumor/T2 values of gluteus maximus muscle) (T2a), maximum cross-sectional area of tumor on diffusion-weighted imaging (SDWI) and T2-weight (ST2), the numbers of lymph node metastases (LNN) and diameter of lymph node (LND), were measured by two experienced readers independently. In addition, the changes in MRI parameters relative to baseline were calculated. Spearman’s correlation coefficient and Wilcoxon’s rank sum test were used to assess association between MRI parameters and complete response (CR). Cox regression was used to evaluate association between MRI parameters and OS/DFS. We analyzed MRI images of 52 patients who underwent TNT from 2015 to 2017 retrospectively. Among them, there were 22 patients (42%) who achieved CR, including 15 pathologic CR (pCR) in those who underwent surgery and 7 clinical CR (cCR). The median follow-up was 30 months (11-39 months). As to the baseline MRI parameters, only ADC was correlated with CR (r=0.312, p=0.026). 1 and 2-year OS rate of the whole cohort was 98.1% and 93.2%, respectively. 1 and 2-year DFS rate were 92.3% and 84.3%, respectively. Multivariate analysis showed that baseline T2a ≥5 (HR 0.048, 95% CI 0.009 - 0.265; p<0.001) and baseline SDWI ≥2cm2 (HR 17.875, 95% CI 1.854-172.306; p=0.013) were independent prognostic factors for unfavorable DFS. There were 25 patients who had complete baseline, post-CRT, and post-CCT MRI images. For these patients, baseline ADC (r=0.544, p=0.005), post-CCT ADC (r=0.522, p=0.007), ΔADC (post-CCT relative to baseline) (r=0.522, p=0.007), post-CRT LNN (r=-0.400, p=0.047), ΔLNN (post-CRT relative to baseline) (r=0.677, p=0.000199), and ΔLND (post-CRT relative to baseline) (r=0.594, p=0.002) were correlated with CR. ΔSDWI (post-CRT relative to baseline) >30 cm2 (HR 0.036, 95% CI 0.004 - 0.363; p=0.005) was independent prognostic factor for better DFS. Baseline ADC, ΔADC, ΔLNN, and ΔLND seem to have correlation with response to TNT. T2 adjusted value, baseline SDWI and ΔSDWI > 30 cm2 might relate to better DFS.

MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer

Diagnostic performance of endoscopy and MRI in identifying true response among patients with rectal cancer treated with total neoadjuvant therapy and selective watch and wait or TME.

Watch & wait - Post neoadjuvant imaging for rectal cancer

MRI-predicted extramural vascular invasion and tumour deposit are main predictors of disease-free survival in patients undergoing surgical resection for rectal cancer

The Value Of Magnetic Resonance Imaging To Assessing Response And Prognosis To Total Neoadjuvant Treatment (Tnt) In Locally Advanced Rectal Cancer

Predicting Response to Total Neoadjuvant Treatment (TNT) in Locally Advanced Rectal Cancer Based on Multiparametric Magnetic Resonance Imaging: A Retrospective Study.

Characteristics And Prognostic Significance Of Preoperative Magnetic Resonance Imaging-Assessed Circumferential Margin In Rectal Cancer

FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study

The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer

Radiomic Features Are Predictive of Response in Rectal Cancer Undergoing Therapy

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection

The importance of MRI for rectal cancer evaluation

Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial

Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study

Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT)

The significance of mucin on rectal MRI in patients with locally advanced rectal cancer being considered for watch-and-wait after neoadjuvant therapy.

Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development

Magnetic Resonance Imaging in Restaging Rectal Cancer after Neoadjuvant Chemoradiotherapy.

Prognostic risk factors and survival models for T3 locally advanced rectal cancer: what can we learn from the baseline MRI?

Advances in MRI-Based Assessment of Rectal Cancer Post-Neoadjuvant Therapy: A Comprehensive Review

Is There a Benefit in Using Magnetic Resonance Imaging in the Prediction of Preoperative Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer?